van Impel, Andreas2; Zhao, Zhonghua3; Hermkens, Dorien M A3; Roukens, M Guy3; Fischer, Johanna C3; Peterson-Maduro, Josi3; Duckers, Henricus3; Ober, Elke4; Ingham, Philip W3; Schulte-Merker, Stefan3
1 Laboratory, The Danish Stem Cell Center, Faculty of Health and Medical Sciences, Københavns Universitet2 Hubrecht Institute - KNAW & UMC Utrecht, 3584 CT Utrecht, The Netherlands.3 unknown4 Laboratory, The Danish Stem Cell Center, Faculty of Health and Medical Sciences, Københavns Universitet
In mammals, the homeodomain transcription factor Prox1 acts as the central regulator of lymphatic cell fate. Its restricted expression in a subset of cardinal vein cells leads to a switch towards lymphatic specification and hence represents a prerequisite for the initiation of lymphangiogenesis. Murine Prox1-null embryos lack lymphatic structures, and sustained expression of Prox1 is indispensable for the maintenance of lymphatic cell fate even at adult stages, highlighting the unique importance of this gene for the lymphatic lineage. Whether this pre-eminent role of Prox1 within the lymphatic vasculature is conserved in other vertebrate classes has remained unresolved, mainly owing to the lack of availability of loss-of-function mutants. Here, we re-examine the role of Prox1a in zebrafish lymphangiogenesis. First, using a transgenic reporter line, we show that prox1a is initially expressed in different endothelial compartments, becoming restricted to lymphatic endothelial cells only at later stages. Second, using targeted mutagenesis, we show that Prox1a is dispensable for lymphatic specification and subsequent lymphangiogenesis in zebrafish. In line with this result, we found that the functionally related transcription factors Coup-TFII and Sox18 are also dispensable for lymphangiogenesis. Together, these findings suggest that lymphatic commitment in zebrafish and mice is controlled in fundamentally different ways.
Development (cambridge), 2014, Vol 141, Issue 6, p. 1228-38